• News
  • SAN DIEGO
  • BioTech

Zogenix developing abuse-deterrent painkiller

The San Diego company that makes the powerful new prescription painkiller Zohydro is selling off its migraine therapy business to focus on developing abuse-resistant forms of Zohydro.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Zogenix Inc.

Company Website

12400 High Bluff Dr. Ste., 650
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ZGNX
1.38
  0.05  
+ 3.76%
1,785,920,000
5.19
1.07

Zogenix Inc. Executive(s):

Roger Hawley

  • Chief Executive Officer

Stephen Farr

  • President

Ann Rhoads

  • Chief Financial Officer
Subscribe Today!